Pfizer Addresses Proposal for Metsera

Go back to Pfizer Addresses Proposal for Metsera

Pfizer earnings preview: Leerink trims estimates

November 3, 2025 4:00 PM UTC

Pfizer (NYSE: PFE) is set to report third-quarter results on Nov. 4, with analysts at Leerink Partners lowering earnings forecasts ahead of the release.

Leerink reduced its third-quarter earnings-per-share estimate by $0.10, or 13%, to $0.70, and full-year 2025 EPS by 3% to $3.04, within company guidance ($2.90$3.10).

The firm said it cut its 2025 Paxlovid... More